You are currently viewing a new version of our website. To view the old version click .

Gastrointestinal Cancers: Advances in Diagnostic, Prognostic, and Therapeutics

This special issue belongs to the section “Cancer Causes, Screening and Diagnosis“.

Special Issue Information

Dear Colleagues,

Gastrointestinal cancers comprise a wide array of tumors interesting the whole gastrointestinal tract. As reported by the World Health Organization, approximately 3.5 million new gastrointestinal cancer cases were diagnosed worldwide in 2018. Notably, colorectal cancer and gastric cancer are the third and fifth most frequent types of cancer, respectively and are amongst the fifth most common causes of cancer-related death worldwide. Despite the advancement that increased early diagnostic rates and more efficient treatment strategies, these types of cancers are burdened by high mortality rates.

We are pleased to invite you to submit your manuscripts related to the aim of this special issue, which is to report the current advancements in diagnostic and therapeutic strategies and better prognostic stratification for gastrointestinal cancers.

In this Special Issue, basic and clinical studies for original research articles and reviews, are welcome. Research areas may include (but are not limited to) the following:

  • Esophageal, gastric, and duodenal cancers;
  • Biliary and pancreatic cancers;
  • Hepatocellular Carcinoma;
  • Neuroendocrine tumors;
  • Colorectal cancers.

We look forward to receiving your contributions.

Dr. Mauro Giuffrè
Dr. Caecilia Sukowati
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • esophageal cancer
  • gastric cancer
  • pancreatic cancer
  • biliary neoplastic disease
  • neuroendocrine tumors
  • NET
  • colorectal cancer
  • hepatocellular carcinoma
  • screening
  • surgery
  • radiology
  • histology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694